Loading...
XHKG
6160
Market cap195mUSD
Jul 10, Last price  
183.50HKD
1D
0.88%
1Q
-2.96%
IPO
71.50%
Name

Beigene Ltd

Chart & Performance

D1W1MN
XHKG:6160 chart
P/E
4.65
P/S
0.25
EPS
34.09
Div Yield, %
—
Shrs. gr., 5y
6.33%
Rev. gr., 5y
76.85%
Revenues
5.34b
+40.23%
11,148,00013,035,0008,816,0001,070,000238,387,000198,220,000428,212,000308,874,0001,176,283,0001,415,921,0002,458,779,0003,810,241,0005,343,033,000
Net income
287m
P
-7,494,000-18,278,000-57,102,000-119,217,000-93,105,000-673,769,000-950,578,000-1,600,523,000-1,413,354,000-2,003,815,000-881,708,000-644,786,000286,933,000
CFO
1.13b
P
4,073,000-8,694,000-39,843,000-89,513,00012,752,000-547,717,000-750,269,000-1,283,461,000-1,298,723,000-1,496,619,000-1,157,453,000-140,631,0001,127,580,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BeiGene Ltd. is a global biotechnology enterprise, grounded in scientific research, committed to developing groundbreaking and economical pharmaceutical products. Its core mission is to enhance therapeutic outcomes and broaden patient access to critical medicines across the world. The company was co-founded by Xiao Dong Wang and John V. Oyler on October 28, 2010, and its corporate headquarters are situated in George Town, KY.
URL
https://www.beigene.com/
IPO date
Feb 03, 2016
Employees
10,000
Domiciled in
KY
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT